Bafna Pharmaceuticals Limited (NSEI: BAFNAPH)
Health Care · Pharmaceuticals · IN
Rs418.00
+10.36% today · +167.9% 1Y
Bafna Pharmaceuticals Limited (NSEI: BAFNAPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $102.17M and employs 339 people.
Over the last twelve months the share price has gained 167.9%, trading between 94.77 and 418.00.
Tweenvest scores Bafna Pharmaceuticals Limited across four factors: quality 63/100, value 30/100, growth 26/100. Its strongest factor is quality.
BAFNAPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $102.17M
- Revenue (TTM)
- $15.08M
- P/E
- 128.85
- EPS
- 3.24
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- Rs418.00
- 52-week low
- Rs94.77
- Avg volume (3M)
- —
- Shares outstanding
- 23.66M
- Employees
- 339
- Next earnings
- —
About Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
- ISIN
- INE878I01022
- Founded
- 1981
- Listed since
- Dec 28, 2005
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vita Life Sciences LimitedASX: VLS | $104.53M | AU$2.78 | -0.71% |
| Aardvark Therapeutics, Inc.NasdaqGS: AARD | $104.17M | $4.45 | -6.51% |
| Themis Medicare LimitedBSE: 530199 | $103.78M | Rs109.05 | -4.43% |
| PolyPid Ltd.NasdaqCM: PYPD | $102.98M | $5.08 | +0.20% |
| October Pharma S.A.ECASE: OCPH | $101.60M | EGP221.69 | -1.00% |
| RaQualia Pharma Inc.TSE: 4579 | $100.94M | ¥614.00 | +0.82% |
| Intech Biopharm CorporationTPEX: 6461 | $100.75M | NT$29.20 | +10.40% |
| Grown Rogue International Inc.CNSX: GRIN | $99.85M | CA$0.57 | +3.64% |
Figures last refreshed Oct 11, 2026.